(Q41045671)

26 September 2017

1 reference

title

Basal ganglia: new therapeutic approaches to Parkinson's disease (English)

1 reference

26 September 2017

1 reference

Graybiel AM

1

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

26 September 2017

number of pages

4

1 reference

inferred from page(s)

published in

Current Biology

1 reference

26 September 2017

volume

6

1 reference

26 September 2017

issue

4

1 reference

26 September 2017

page(s)

368-371

1 reference

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

A huntingtin-associated protein enriched in brain with implications for pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Altered striatal function in a mutant mouse lacking D1A dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Induction of midbrain dopaminergic neurons by Sonic hedgehog

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Treatment of parkinsonism by stereotatic thermolesions in the pallidal region. A clinical evaluation of 81 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Stereotactic ventral pallidotomy for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Effect of GPi pallidotomy on motor function in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Neurotransmitters and neuromodulators in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900497-9

7 January 2021

10.1016/S0960-9822(02)00497-9

Identifiers

DOI

1 reference

26 September 2017

1 reference